Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


Apr 3, 2023
The AHA is pleased to support the Rural Hospital Support Act (S. 1110).
Mar 29, 2023
New Analysis Shows Physician-owned Hospitals Cherry-pick Patients, Provide Less Uncompensated and Emergency Care.
Mar 29, 2023
AHA's feedback on a Drug Enforcement Administration proposed rule for the telemedicine prescribing of controlled substances when there has not been a prior in-person medical evaluation.
Mar 29, 2023
AHA provides feedback on the Drug Enforcement Administration’s (DEA’s) proposed rule for expansion of induction of buprenorphine via telemedicine encounter.
Mar 29, 2023
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
Mar 28, 2023
The AHA writes to express support for the Rural America Health Corps Act (S.940).
Mar 23, 2023
AHA provides information for hearing on “Why Health Care is Unaffordable: The Fallout of Democrats’ Inflation on Patients and Small Businesses.”
Mar 22, 2023
AHA, health organizations request increased funding for Children's Hospitals Graduate Medical Education Program.
Mar 21, 2023
AHA comments on the proposed Standards for Health Care Attachments Transactions and Electronic Signatures, and Modification to Referral Certification and Authorization Transaction Standard.